Barclays reaffirmed their neutral rating on shares of Johnson Matthey (LON:JMAT – Get Rating) in a research report report published on Thursday morning, MarketBeat Ratings reports. Barclays currently has a GBX 1,900 ($22.47) price objective on the stock.
Other analysts also recently issued reports about the company. Citigroup reiterated a neutral rating and set a GBX 2,200 ($26.01) target price on shares of Johnson Matthey in a research report on Friday, August 12th. Berenberg Bank raised their price target on Johnson Matthey from GBX 2,200 ($26.01) to GBX 2,350 ($27.79) and gave the company a buy rating in a research note on Thursday. Finally, JPMorgan Chase & Co. cut their price target on Johnson Matthey from GBX 2,600 ($30.74) to GBX 2,150 ($25.42) and set a neutral rating on the stock in a research note on Tuesday, October 11th. Six investment analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of Hold and a consensus target price of GBX 2,205.71 ($26.08).
Johnson Matthey Stock Down 0.8 %
LON:JMAT opened at GBX 2,125 ($25.13) on Thursday. Johnson Matthey has a twelve month low of GBX 1,650 ($19.51) and a twelve month high of GBX 2,536 ($29.99). The company has a market cap of £3.90 billion and a price-to-earnings ratio of 3,511.48. The stock has a fifty day simple moving average of GBX 1,949.64 and a 200-day simple moving average of GBX 2,044.56. The company has a current ratio of 1.33, a quick ratio of 0.68 and a debt-to-equity ratio of 51.33.
Johnson Matthey Cuts Dividend
Insider Buying and Selling at Johnson Matthey
In related news, insider Stephen Oxley bought 21 shares of the business’s stock in a transaction on Wednesday, October 19th. The shares were bought at an average price of GBX 1,907 ($22.55) per share, for a total transaction of £400.47 ($473.54). In related news, insider Stephen Oxley bought 21 shares of the business’s stock in a transaction on Wednesday, October 19th. The shares were bought at an average price of GBX 1,907 ($22.55) per share, for a total transaction of £400.47 ($473.54). Also, insider Chris Mottershead bought 166 shares of the business’s stock in a transaction on Thursday, September 29th. The stock was bought at an average price of GBX 1,789 ($21.15) per share, for a total transaction of £2,969.74 ($3,511.58). Insiders have purchased 208 shares of company stock worth $377,047 over the last quarter.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
- Microsoft Shares: Is it Time to Back Up the Truck?
- Is the 60/40 Portfolio Mix Still in Vogue?
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Institutional Support for Analog Devices Remains High
- Three CBD Stocks to Dominate a Budding Industry
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.